Diagnosis and Management of Overflow Incontinence
Diagnostic Evaluation
- Post-void residual (PVR) measurement is essential for patients with suspected overflow incontinence, with elevated PVR (typically >250-300 mL) suggesting overflow incontinence, according to the American Urological Association 1
- Urinalysis should be performed to rule out urinary tract infection and hematuria, as recommended by the American Urological Association 2
- Careful physical examination, including abdominal, rectal/genitourinary exam, is necessary to identify possible causes of obstruction, as suggested by the American Urological Association 1
Treatment Considerations
- Antimuscarinic medications used for overactive bladder should be avoided or used with extreme caution in patients with elevated PVR (>250-300 mL) as they may worsen retention, according to the American Urological Association 1
- Indwelling catheters should be avoided except as a last resort due to high risk of urinary tract infections, urethral erosion, and urolithiasis, as warned by the American Urological Association 3
- When intermittent catheterization is required, patients must be willing and able to perform the procedure or have caregiver support, as emphasized by the American Urological Association 3
Follow-up and Monitoring
- Regular assessment of treatment efficacy and side effects is necessary, as recommended by the American Urological Association 4
- Monitoring of post-void residual volumes is essential to ensure improvement, according to the American Urological Association 1
- Reassessment is necessary if treatment goals are not met, as suggested by the American Urological Association 5
Common Pitfalls
- Misdiagnosing overflow incontinence as overactive bladder can lead to inappropriate treatment with antimuscarinics, potentially worsening the condition, as cautioned by the American Urological Association 1
- Failure to measure post-void residual in patients with incontinence may miss this diagnosis, as warned by the American Urological Association 1
- Not considering medication side effects as potential contributors to overflow incontinence is a common pitfall, as noted by the American Urological Association 1